Pulmonary Embolism With Acute Cor Pulmonale: Clinical Trials

4 trials for Pulmonary Embolism With Acute Cor Pulmonale, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 terminated, 1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Pulmonary Embolism With Acute Cor Pulmonale: new trials by email Literature Review of Pulmonary Embolism With Acute Cor Pulmonale trials Research Report on Pulmonary Embolism With Acute Cor Pulmonale

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Repeated Examinations for Typing Pulmonary Embolism
Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
RecruitingSahlgrenska University Hospital4002026-04-012026-10-13
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
Alteplase, Unfractionated heparin, Placebo - Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism
Phase 4TerminatedVictor Tapson, MD42019-07-252021-06-11
Catheter-directed Thrombectomy in High and Intermediate-high Risk Pulmonary Embolism
Catheter-directed thrombectomy - Pulmonary Embolism With Acute Cor Pulmonale
UnknownPoznan University of Medical Sciences1002018-10-012020-08-18
Polish Multicenter PERTs PE Outcomes Registry
Pulmonary Embolism With Acute Cor Pulmonale
RecruitingPoznan University of Medical Sciences100002018-06-012021-05-10

Narrower conditions

Pulmonary Embolism (4)  ·  Clinical Deterioration (1)  ·  Death (1)  ·  Disease (1)  ·  Heart Failure (1)  ·  Ventricular Dysfunction, Right (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Embolism (4)  ·  Embolism and Thrombosis (4)  ·  Lung Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Vascular Diseases (4)  ·  Disease Attributes (1)  ·  Disease Progression (1)  ·  Heart Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Ventricular Dysfunction (1)

Interventions

Heparin (1)  ·  Tissue Plasminogen Activator (1)  ·  apixaban (1)

Sponsors

Poznan University of Medical Sciences (2)  ·  Sahlgrenska University Hospital (1)  ·  Victor Tapson, MD (1)

Countries

Poland (2)  ·  Sweden (1)  ·  United States (1)

Top investigators

Aaron S Weinberg, MD (1)  ·  Aleksander Araszkiewicz, Assoc. Prof. (1)  ·  Aleksander Araszkiewicz, Prof. (1)  ·  Victor F Tapson, MD (1)

Results publications

PMID 40045310